New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...

People with mental health problems could be prioritised for weight loss jabs, experts have suggested, after a study showed ...

Research presented at the the European Congress on Obesity suggests weight loss injections are safe and work for the mentally ...

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...

Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for ...

GLP-1 analogues, typically prescribed for weight loss, led to a 68% reduction in alcohol intake among regular drinkers.

She says they have done what the diet industry could never do for her - free her from a life controlled by food. From a very ...

The weight-loss drug revolution is reshaping the health and wellness industry, forcing companies to adapt or face the same ...

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business ...

Neurologist Dr. Leah Croll talks about the new research suggesting they might help in treating people with alcohol use ...